Impact of drugs on survival of patients with non-muscle invasive urothelial carcinoma of the bladder and patients after radical cystectomy.

Impact of drugs on survival of patients with non-muscle invasive urothelial carcinoma of the bladder and patients after radical cystectomy. - BLUME

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017080

Enrollment

1000

Registered

2019-10-11

Start date

2019-10-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C67

Interventions

Group 1: We are conducting a prospective, monocentric, non-interventional observational study at the Department of Urology. Included are all consenting adult patients with a primary diagnosis of non-m

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with primary diagnosis urinary bladder cancer and patients with planned radical cystectomy; Patients that are able to give consent and information on their medication.

Exclusion criteria

Exclusion criteria: Known metastasis at the time of study inculsion.

Design outcomes

Primary

Measure	Time frame
cancer specific survival and progression free survival. Collected every 3 month during follow-up (interview via telephone with patient or relatives), medical records from urologic check-up by GP	—

Secondary

Measure	Time frame
overall survival. Collected every 3 month during follow-up (interview via telephone with patient or relatives)	—

Countries

Germany

Contacts

Public ContactLisa Hurm

Klinikum der Universität München

lisa.hurm@med.uni-muenchen.de089440076600

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 20, 2026